Heartfelt with Dr Melissa Walton-Shirley

 
 

Heartfelt with Dr Melissa Walton-Shirley

  • Closing the Office Door for the Last Time With a heavy heart, Melissa Walton-Shirley bids farewell to full-time practice. Ailing parents and RVU demands drive this transition to a new stage in her career.
  • ESC 2018 Do Cardiologists Care About CV Prevention? Everyone agrees that prevention is better than cure. However, few ESC attendees joined Melissa Walton-Shirley for the session on CVD prevention, preferring to stand in line to hear the latest hotlines.
  • ESC 2018 Cardiology 2028: Predicting the Future Melissa Walton-Shirley attended a session at the European Society of Cardiology Congress titled "Cardiology 10 Years From Now" and heard some realistic predictions.
  • ESC 2018 What's Driving Physician Burnout in 2018? At a session on burnout at the ESC meeting in Munich, Dr Walton-Shirley heard a first-hand account of a cardiologist who had a breakdown. The panelists left her hopeful that things will improve.
  • ESC 2018 Overprescribing in the Elderly: We Have a Problem Melissa Walton-Shirley sat in on a presentation about polypharmacy in older patients and learned some surprising statistics.
  • When EHRs (and Doctors) Don't Communicate With Each Other When requests for medical records draw no response, time and money are wasted. Can't we do better in the age of electronic health records, asks Melissa Walton-Shirley.
  • Pricey Pee: Time to Regulate Vitamin and Dietary Supplements Multiple studies show that dietary supplements result in little more than expensive urine and in some cases may even cause harm. Melissa Walton-Shirley thinks it's high time they were better regulated.
  • The Death of Yarushka Rivera: Prior Authorization Run Amok A teen suffered tragic consequences from a failed prior authorization; Melissa Walton-Shirley says lawsuits miss the mark.
  • IV Diltiazem and Other Shortages at Crisis Level A confluence of factors, including a hurricane, have left hospitals with shortages of saline and IV drugs. But long-term solutions will require the intervention of legislators, concludes Melissa Walton-Shirley, MD.
  • For the Quadruple Aim to Succeed, Keep Doctors Doctoring An article by the ACC president on helping cardiologists find work-life balance leads Dr Walton-Shirley to detail what exactly needs to happen to make it a reality vs wishful thinking.
  • ACC 2018 MOMENTUM-3: The Future of the LVAD Is Here and Now A trial showing better outcomes for HeartMate 3 over HeartMate II sends Dr Walton-Shirley down memory lane to recall the patients she has referred for implantation of a left ventricular assist device (LVAD).
  • ACC 2018 Another Way to Save a Life: the MANAGE Trial Dr Walton-Shirley was impressed by a study on dabigatran for myocardial injury after noncardiac surgery at the American College of Cardiology Annual Scientific Session.
  • ACC 2018 How Want Became Need With ODYSSEY Dr Walton-Shirley would like to prescribe more PCSK9 inhibitors, given positive data from the American College of Cardiology meeting, but the prior authorization process may break her first.
  • The Slam Dunk NSTEMI That Was Almost an Epic Fail Using a basketball analogy, Dr Walton-Shirley describes a case that bounced around a number of healthcare professionals who almost 'dropped the ball.'
  • Did Grey's Anatomy Get It Right for Women With Heart Disease? An episode of the hospital drama featured a female surgeon having a heart attack but meeting disbelief (including her own) along the way. TV critic and cardiologist Dr Walton-Shirley gives her review.
  • CVS-Aetna Deal Turns Up the Heat on Physicians The proposed merger of CVS and Aetna exemplifies the devolution of medicine to a business rather than a caring profession, warns Dr Melissa Walton-Shirley.
  • Strategies for Managing Frequent-Flier Patients From the worried well to the at-risk but noncompliant patient, Dr Walton-Shirley reviews the frequent fliers that she has encountered in her many years of practice.
  • AHA HOPE-Duchenne and Help at Last The final day of AHA 2017 brought Dr Walton Shirley to tears with studies offering hope to ease the suffering she has witnessed firsthand.
  • AHA Gastric Bypass for the Less Obese? Dr Walton-Shirley is reluctant to send obese patients for gastric bypass surgery, but concedes that the GATEWAY study findings are impressive.
  • AHA Trials We Did, Trials We Should Do Dr Walton-Shirley reflects on some major studies presented at AHA 2017 and offers a further way to approach each one.
https://medicaments-24.net

Купить Авана 50

https://pharmacy24.com.ua